“The usefulness of biotechnology firms’ drug development status in the evaluation of research and development costs”

Research output: Contribution to journalArticleProfessional

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)197-205
JournalJournal of accounting, auditing & finance
Volume18
Issue number1
Publication statusPublished - 2003
Externally publishedYes

Cite this